Latest News

Q&A: How AI Is Reshaping Clinical Operations and Study Feasibility
Q&A: How AI Is Reshaping Clinical Operations and Study Feasibility

August 14th 2025

In this Q&A, Rohit Nambisan, CEO of Lokavant, and Jonathan Crowther, head of predictive analytics, Pfizer, explore how AI is transforming study feasibility, regulatory review, and trial execution.

© Kaikoro - © Kaikoro - stock.adobe.com
AI-Powered Non-Interventional Research Delivers What DCTs Promised

August 8th 2025

© JHVEPhoto - ©  JHVEPhoto - stock.adobe.com
FDA’s Elsa AI Tool Raises Accuracy and Oversight Concerns

July 23rd 2025

 Empowering the Workforce of the Future: The Trends and Training That Will Drive the Future of Drug Development
Empowering the Workforce of the Future: The Trends and Training That Will Drive the Future of Drug Development

July 15th 2025

The 50-Year Technology Drought in Clinical Trials: How AI Teammates Will Finally Bring Us Into the Modern Era
The 50-Year Technology Drought in Clinical Trials: How AI Teammates Will Finally Bring Us Into the Modern Era

July 11th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.